None listed
Conditions
Brief summary
This study aims to test the feasibility and effectiveness of a multi-component non-pharmacological intervention in improving breathlessness management for lung cancer patients. Who is it for? You may be eligible to join this study if you are aged 18 years or above, and have been diagnosed with a primary or secondary lung cancer with a life expectancy of at least 3 months. You should have completed first line therapy, and have an average breathlessness rating of >2 on an 11 point scale in the past week. Trial details Participants in this trial will be randomly (by chance) allocated to one of two groups. Participants in one group will receive a multi-component intervention that incorporates a range of strategies to manage breathlessness and related symptoms (e.g. breathing retraining, psychosocial support and management of other co-occurring symptoms) at one face-to-face instructional session of about 60 minutes, followed up by weekly calls to reinforce the interventions for 3 weeks. It will be delivered by experienced registered nurses trained in these techniques who will facilitate follow-up with relevant primary care/community supports. Participants in the other group will receive standard non-pharmacological interventions to manage breathlessness. Participants will be assessed at recruitment and at 4 weeks and 8 weeks post treatment in order to determine the feasibility and efficacy of the intervention in improving breathlessness, anxiety, depression and co-occurring symptoms (cough, pain fatigue, anorexia).
Interventions
The intervention combines breathing re-training with individualised psychosocial support, delivered using evidence based psycho-educational strategies to improve breathlessness and additional intervention components which focus on reducing the impact of co-occurring symptoms on dyspnoea (cough, pain, fatigue, anorexia) in the form of a face-to-face instructional session of about 60 minutes delivered by experienced registered nurses, followed by weekly phone calls for 3 weeks. The instruction is
The intervention combines breathing re-training with individualised psychosocial support, delivered using evidence based psycho-educational strategies to improve breathlessness and additional intervention components which focus on reducing the impact of co-occurring symptoms on dyspnoea (cough, pain, fatigue, anorexia) in the form of a face-to-face instructional session of about 60 minutes delivered by experienced registered nurses, followed by weekly phone calls for 3 weeks. The instruction is supplemented by a range of resources to reinforce intervention delivery and promote self-management, including audio recordings, printed fact sheets, an individualised management plan, as well as communication and referral to a relevant health provider in the community (GP, Practice Nurse or Community/Domiciliary Nurse).
Sponsors
Queensland University of Technology
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Diagnosed with a primary or secondary lung cancer; life expectancy of at least 3 months; completed first line therapy; have an average dyspnoea rating > 2 on an 11 point numeric rating scale in the past week
Exclusion criteria
< 18 years; have an intellectual or mental impairment; primary language other than English
Outcome results
None listed